Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The Starr Edwards was the first ...

Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Study Overview: Edwards Lifesciences Corp. is conducting ...

A Delaware judge correctly interpreted transcatheter aortic valve-replacement device patents that were asserted against ...

NEWBURY, England--(BUSINESS WIRE)--Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration (SVD) in bioprosthetic aortic ...

Edwards Lifesciences Corp. (($EW)) announced an update on their ongoing clinical study. Study Overview: Edwards Lifesciences Corp. is conducting a ...

Edwards Lifesciences Corp. says it won’t go back to the drawing board after a setback on a heart valve the company sees as a growing part of its business. The issue arose after Edwards said the ...

The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...

Investors drove down shares of Irvine heart valve maker Edwards Lifesciences Corp. after an analyst downgraded the company’s stock on concerns about a new type of heart valve. In a note to clients, ...

Edwards Lifesciences Corp.'s Sapien aortic heart valve caused complications in a trial when inserted directly into the heart, leading researchers to halt the study, according to an analyst from Wells ...

CHICAGO (Reuters) - Edwards LifeSciences Corp's less-invasive replacement heart valve alleviates symptoms such as fatigue and breathlessness better than standard medical therapy, data released on ...

WASHINGTON (Reuters) - The minimally invasive aortic heart valve replacement system from Edwards Lifesciences Corp performed better than a rival product sold by Medtronic Inc in the first head-to-head ...